This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Author: Avi Kapoor | November 17, 2025 08:14am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

BTIG analyst Thomas Shrader initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $27. Alto Neuroscience shares closed at $12.11 on Friday. See how other analysts view this stock.
B of A Securities analyst Travis Steed initiated coverage on Masimo Corporation (NASDAQ:MASI) with a Neutral rating and announced a price target of $162. Masimo shares closed at $151.12 on Friday. See how other analysts view this stock.
Leerink Partners analyst Marc Goodman initiated coverage on Ovid Therapeutics Inc. (NASDAQ:OVID) with an Outperform rating and announced a price target of $5. Ovid Therapeutics shares closed at $1.3050 on Friday. See how other analysts view this stock.
HC Wainwright & Co. analyst Yi Chen initiated coverage on Vivos Therapeutics, Inc. (NASDAQ:VVOS) with a Buy rating and announced a price target of $7. Vivos Therapeutics closed at $2.34 on Friday. See how other analysts view this stock.
Benchmark initiated coverage on TAT Technologies Ltd. (NASDAQ:TATT) with a Buy rating and announced a price target of $53. TAT Technologies shares closed at $40.04 on Friday. See how other analysts view this stock.